Panthera Biopartners

CRO
Seed Investment
2020-2022

Panthera recruits patients and runs clinical trials on behalf of Contract Research Organisations and pharmaceutical companies developing new drugs. It has a specialism in oncology, NASH, neurology and vaccines.

The business received a seed investment from GM&C to help establish new sites, including in Rochdale, and secure its first customers.

Within two years, Panthera had become one of the fastest growing companies in the UK securing millions of pounds of clinical trial contracts. GM&C exited when the company raised £10m in growth capital for further expansion, resulting in a 3.3x cash return and an IRR of 115.6%.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email